Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 18, 2024 1:01 PM 4 min read

96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?

by Piero Cingari Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Ninety-six percent, or 480 out of the 500 companies comprising the S&P 500 index, are trading at lower market values compared to Wall Street analysts’ price targets, signaling abundant potential profit opportunities for investors.

Thus far, April has marked the bleakest month for the U.S. stock market since September 2023, with the S&P 500 index, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), falling by 3.7%.

Across all 11 sectors constituting the index, only the Energy Select Sector SPDR Fund (NYSE:XLE) has managed to evade losses. The Real Estate Select Sector SPDR Fund (NYSE:XLRE) emerged as the month’s weakest performer, experiencing a 10% downturn.

Higher-than-expected inflation figures have placed downward pressure on stocks, leading to reduced expectations for Federal Reserve rate cuts. As of April 18, investors expect fewer than two rate cuts, down from over three anticipated at the beginning of the month.

Simultaneously, mounting geopolitical risks stemming from the ongoing Middle East crisis have amplified market uncertainties.

However, this phase of increased volatility has subdued the once prevalent bullish sentiment that persisted until the end of March, uncovering attractive opportunities for investors who favor buying the dips of undervalued stocks.

Presented herein are the top 5 contrarian stocks within the S&P 500 index exhibiting the most pronounced relative gap between current market prices and median price targets.

5. Carnival Corporation

Carnival Corp. (NYSE:CCL) has experienced a noticeable downturn, dropping by 11.54% this month and 22.03% year-to-date.

Analysts, however, have maintained consistency in their price forecasts. At the beginning of the year, the median target was $20.78, which has since held steady at $22.

This suggests a substantial 52.20% potential upside from the current trading price of $14.46 per share.

4. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (NYSE:BIO) has witnessed an 18.81% decline in price this month and a 13.03% decrease year-to-date.

Despite market fluctuations, the median price target has remained unchanged at $436.70 since the beginning of 2024.

Presently trading at $280.81 per share, this implies that analysts see a potential upside of 55.51% if the stock price converges with the target.

3. Warner Bros. Discovery, Inc.

Warner Bros. Discovery, Inc. (NASDAQ:WBD) has declined 5.27% this month and by a substantial 27.33% year-to-date.

Analysts have downwardly adjusted their price targets for WBD shares, reducing the median level from $16.64 at the beginning of the year to $13 presently.

Despite these downward revisions, the current share price of $8.27 still provides some margin of safety to investors, indicating a potential 57.19% upside if it converges with analysts’ targets.

2. Caesars Entertainment Inc.

Caesars Entertainment Inc. (NYSE:CZR) has declined by 11.25% month-to-date and a more substantial 17.19% year-to-date.

However, despite these negative trends, analysts have made minimal adjustments to their price targets for the casino-related company.

With the current trading price at $38.32, the median price target of $62.50 suggests a significant profit potential of 61% if the current price aligns with analysts’ expectations.

1. Globe Life Inc.

Globe Life Inc. (NYSE:GL) faced a tumultuous April, plummeting by a staggering 50% due to a critical report by short seller Fuzzy Panda Research.

Despite this, since hitting its lows on April 11, the shares have rebounded by 66%, though remaining still well below pre-report levels.

Despite a slight reduction in Wall Street analysts’ price targets, down from $136 to $130 in the past month, the current stock price of $64.98 presents an enticing short-squeeze opportunity, suggesting a profit potential of 100% if investors can counter and push back against Fuzzy Panda’s bearish pressure.

Chart: Will Globe Life Be Able To Squeeze Short Sellers?

Read now: Most S&P 500 Stocks No Longer Trade Above 50-Day Average: Healthy Pullback Or Is The Bull Market Over?

Image generated using artificial intelligence via Midjourney.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
BiotechEquitiesLarge CapMid CapShort SellersBroad U.S. Equity ETFsPrice TargetTravelTop StoriesTechETFsExpert IdeasStories That Matter
BIO Logo
BIOBio-Rad Laboratories Inc
$271.44-%
Overview
CCL Logo
CCLCarnival Corp
$26.23-0.59%
CZR Logo
CZRCaesars Entertainment Inc
$25.73-0.12%
GL Logo
GLGlobe Life Inc
$142.01-0.12%
SPY Logo
SPYState Street SPDR S&P 500 ETF Trust
$675.34-0.43%
WBD Logo
WBDWarner Bros. Discovery Inc
$27.760.04%
XLE Logo
XLEState Street Energy Select Sector SPDR ETF
$55.75-1.01%
XLRE Logo
XLREState Street Real Estate Select Sector SPDR ETF
Not Available-%
NamePrice Target vs. Last PriceLast PricePrice Target – MedianPrice Median 1Month Ago)Price Target (2024 start)Price Chg. % (MTD)Price Chg. % (YTD)
Globe Life Inc.100.05%64.98130.00136.00133.56-44.16%-46.61%
Caesars Entertainment, Inc.61.00%38.8262.5063.0062.33-11.25%-17.19%
Warner Bros. Discovery, Inc.57.19%8.2713.0013.2016.64-5.27%-27.33%
Bio-Rad Laboratories, Inc.55.51%280.81436.70436.70436.67-18.81%-13.03%
Carnival Corporation & plc52.20%14.4622.0022.0020.78-11.54%-22.03%
BIO Logo
BIOBio-Rad Laboratories Inc
$271.44-%
Overview
CCL Logo
CCLCarnival Corp
$26.23-0.59%
CZR Logo
CZRCaesars Entertainment Inc
$25.73-0.12%
GL Logo
GLGlobe Life Inc
$142.01-0.12%
SPY Logo
SPYState Street SPDR S&P 500 ETF Trust
$675.34-0.43%
WBD Logo
WBDWarner Bros. Discovery Inc
$27.760.04%
XLE Logo
XLEState Street Energy Select Sector SPDR ETF
$55.75-1.01%
XLRE Logo
XLREState Street Real Estate Select Sector SPDR ETF
Not Available-%
Comments
Loading...